American Journal of Kidney Diseases 2011-04-01

Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy.

Leonardo V Riella, Helmut G Rennke, Monica Grafals, Anil Chandraker

Index: Am. J. Kidney Dis. 57(4) , 641-5, (2011)

Full Text: HTML

Abstract

Hypophosphatemia is a common complication after kidney transplant, affecting >90% of patients. However, no specific recommendations for phosphate repletion exist for transplant recipients. We report a case of a 70-year-old highly sensitized woman with end-stage renal disease caused by diabetic nephropathy who underwent deceased donor kidney transplant. Four weeks later, she was noted to have hypophosphatemia with undetectable serum phosphate levels, and she reported mild diarrhea. She was started on oral phosphate supplementation. On a routine visit 2 weeks later, she was found to have an acute increase in serum creatinine level and kidney biopsy was performed. We discuss the causes, management, and complications of hypophosphatemia in kidney transplant.Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.


Related Compounds

  • Calcium acetate

Related Articles:

Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease.

2014-07-01

[Clin. Nephrol. 82(1) , 16-25, (2014)]

Immune quiescence of the brain is set by astroglial connexin 43.

2015-03-11

[J. Neurosci. 35(10) , 4427-39, (2015)]

HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma.

2015-02-01

[Exp. Cell Res. 331(1) , 46-57, (2015)]

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.

2013-10-12

[Lancet 382(9900) , 1268-77, (2013)]

Absorption of levothyroxine when coadministered with various calcium formulations.

2011-05-01

[Thyroid 21(5) , 483-6, (2011)]

More Articles...